Vaishali Suri Selected Research

Biomarkers (Surrogate Marker)

2/2024	MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas.
8/2023	Decanoic acid mitigates ischemia reperfusion injury by modulating neuroprotective, inflammatory and oxidative pathways in middle cerebral artery occlusion model of stroke in rats.
1/2022	Upregulation of Atypical Cadherin FAT1 Promotes an Immunosuppressive Tumor Microenvironment via TGF-β.
12/2021	Molecular alterations of low-grade gliomas in young patients: Strategies and platforms for routine evaluation.
4/2016	Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors.
7/2014	Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: Adjuncts to histopathological grading and predictors of aggressive behavior.
1/2014	Sperm associated antigen 9 (SPAG9) expression and humoral response in benign and malignant salivary gland tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vaishali Suri Research Topics

Disease

41	Neoplasms (Cancer) 04/2024 - 02/2009
17	Glioma (Gliomas) 12/2023 - 09/2009
13	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 12/2010
11	Ependymoma 02/2024 - 01/2014
6	Meningioma (Meningiomas) 01/2024 - 07/2014
5	Carcinoma (Carcinomatosis) 10/2019 - 03/2010
4	Residual Neoplasm 03/2020 - 05/2015
3	Astrocytoma (Pilocytic Astrocytoma) 12/2023 - 08/2022
3	Inflammation (Inflammations) 12/2023 - 10/2018
3	Oligodendroglioma 08/2018 - 09/2009
3	Seizures (Absence Seizure) 09/2017 - 02/2010
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2023 - 08/2023
2	Stroke (Strokes) 12/2023 - 08/2023
2	Infarction (Infarctions) 12/2023 - 08/2023
2	Primitive Neuroectodermal Tumors (PNET) 07/2021 - 01/2021
2	Focal Cortical Dysplasia 06/2020 - 09/2017
2	Tuberous Sclerosis (Bourneville's Disease) 06/2020 - 09/2016
2	Lymphoma (Lymphomas) 01/2018 - 04/2015
2	Medulloblastoma 11/2016 - 07/2009
2	Neoplasm Metastasis (Metastasis) 07/2016 - 01/2015
1	Brain Neoplasms (Brain Tumor) 06/2024
1	Nelson Syndrome 05/2024
1	Ischemic Stroke 12/2023
1	Reperfusion Injury 08/2023
1	Demyelinating Diseases (Demyelinating Disease) 07/2023
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2023
1	Muscular Dystrophies (Muscular Dystrophy) 09/2022
1	Encephalitis (Encephalitis, Rasmussen) 05/2022

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 12/2023 - 04/2009
9	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 12/2010
9	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2010
7	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2014
5	ErbB Receptors (EGF Receptor)IBA 06/2024 - 09/2009
5	Messenger RNA (mRNA)IBA 04/2024 - 01/2016
5	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 12/2010
5	MethyltransferasesIBA 04/2016 - 12/2010
4	Cadherins (E-Cadherin)IBA 04/2024 - 07/2020
4	MicroRNAs (MicroRNA)IBA 12/2023 - 11/2015
4	Transcription Factors (Transcription Factor)IBA 12/2023 - 10/2018
4	Histones (Histone)IBA 01/2023 - 12/2014
3	Small Interfering RNA (siRNA)IBA 04/2024 - 09/2016
3	EnzymesIBA 01/2024 - 09/2014
3	AntigensIBA 09/2017 - 01/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016 - 04/2011
3	Progesterone Receptors (Progesterone Receptor)IBA 10/2015 - 03/2010
2	CytokinesIBA 12/2023 - 01/2022
2	AMPA Receptors (AMPA Receptor)IBA 12/2023 - 08/2023
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2023 - 03/2022
2	Long Noncoding RNAIBA 08/2022 - 07/2020
2	Phosphotransferases (Kinase)IBA 01/2022 - 02/2016
2	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2021 - 05/2018
2	trans-sodium crocetinate (crocetin)IBA 06/2020 - 09/2016
2	NestinIBA 05/2018 - 10/2014
2	GlycogenIBA 05/2018 - 01/2015
2	Mucin-1 (CA 15-3 Antigen)IBA 01/2018 - 03/2014
2	TOR Serine-Threonine KinasesIBA 09/2017 - 09/2016
2	2,6-dinitrotoluene (DNT)IBA 11/2016 - 04/2009
2	Enhancer of Zeste Homolog 2 ProteinIBA 11/2016 - 10/2015
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 09/2016 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2016 - 01/2014
2	Keratins (Keratin)IBA 03/2014 - 07/2012
2	VimentinIBA 03/2014 - 07/2012
1	N-Myc Proto-Oncogene ProteinIBA 02/2024
1	HexokinaseIBA 01/2024
1	Immune Checkpoint InhibitorsIBA 12/2023
1	PropionatesIBA 12/2023
1	perampanelIBA 12/2023
1	aniracetamIBA 12/2023
1	decanoic acid (capric acid)IBA 08/2023
1	Basic-Leucine Zipper Transcription FactorsIBA 01/2023
1	ApoferritinsIBA 01/2023
1	monodansylcadaverineIBA 01/2023
1	PTX3 proteinIBA 01/2023
1	Folate Receptor 1IBA 01/2023
1	YY1 Transcription FactorIBA 01/2023
1	bafilomycin A1IBA 01/2023
1	tanshinoneIBA 01/2023
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2023
1	isocitrate dehydrogenase (NADP+)IBA 01/2023
1	Heme Oxygenase-1IBA 01/2023
1	ChromatinIBA 01/2023
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023
1	Trichloroacetic AcidIBA 01/2023
1	Coloring Agents (Dyes)IBA 09/2022
1	Congo RedIBA 09/2022
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2022
1	Mediator ComplexIBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	InterleukinsIBA 01/2022
1	Conditioned Culture MediaIBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 12/2021

Therapy/Procedure

14	Therapeutics 01/2023 - 07/2009
9	Radiotherapy 11/2021 - 03/2011
5	Immunotherapy 12/2023 - 03/2014
3	Drug Therapy (Chemotherapy) 12/2013 - 03/2011
2	Adjuvant Radiotherapy 07/2021 - 03/2014
2	Craniotomy 01/2015 - 02/2009
1	Reoperation 05/2024
1	Preoperative Period 07/2022